ViralClear added St. David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
Yale Science Building opened it doors
On Oct. 29, 2019, the Yale Science Building officially opened as a central hub for interdisciplinary collaboration on…
Yale professor Joan Steitz awarded the 2018 Lasker~Koshland Special Achievement Award in Medical Science
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ﾠ…
Yale scientist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal
On Jan. 19, 2018, Yale evolutionary geneticist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal from the…
Connecticut United for Research Excellence (CURE) was renamed BioCT
On Jan. 12, 2018, Connecticut United for Research Excellence Inc. (CURE) renamed itself BioCT and today is the…
Rallybio was founded
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
Biotechnology | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress
The NIH dedicated the Lowell P Weicker building
On May 4, 2015, the National Institutes of Health (NIH) dedicated Building 4 in honor of Lowell P….
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
The Jackson Laboratory for Genomic Medicine opened its doors
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
The Connecticut Development Authority was merged into Connecticut Innovations
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
Precipio was founded
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
Yale’s West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
Yale New Haven Hospital breaks ground on $838 million, 505,000 square foot Neurosciences Center
On Aug. 31, 2022, Yale New Haven Hospital (YNHH) broke ground on the $838 million, 505,000 square foot…
The Kavli Foundation Institute awarded $7.5 million to establish the Institute of Neuroscience at Yale University
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
Bristol-Myers’ Wallingford facility named the Richard L Gelb Center for Pharmaceutical R&D after former Bristol-Myers chair and CEO
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
Connecticut United for Research Excellence (CURE) was founded
In 1990, Connecticut United for Research Excellence Inc. (CURE) was founded. CURE was a statewide coalition of educational…
Connecticut Innovations was founded
In 1989, Connecticut Innovations (CI), created by the Connecticut Legislature, provides strategic capital and operational support to advanced…
Yale Cancer Center oncologists performed the first bone marrow transplant in Connecticut
In 1988, oncologists from Yale Cancer Center performed the first bone marrow transplant in Connecticut at the Yale-New…
CDC Launched National surveillance for Lyme disease
In 1982, the U.S. Centers for Disease Control and Prevention (CDC) launched a national surveillance for tick-borne Lyme…
Joan Steitz discovered snRNPs
In 1979, Joan Steitz discovered snRNPs, RNA-protein complexes in the cell’s nucleus that perform a crucial step in…
Lyme Disease was identified and named
In 1975, Lyme Disease was identified and named at Yale University. The spirochete that causes Lyme disease was…
Yale Cancer Center received NCI-designated comprehensive cancer center status
In 1974, Yale Cancer Center received a National Cancer Institute (NCI) designated comprehensive cancer center status, the only…
Yale established the first university-based department of clinical pharmacology and chemotherapy in the US
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…